GO:0010839 negative regulation of keratinocyte proliferation: Signaling Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0010839 describes any biological process that decreases the rate, frequency or extent of keratinocyte proliferation, thereby limiting epidermal cell population expansion.
• TLR4 signaling acts as a negative regulator of keratinocyte proliferation, and its loss is associated with hyperproliferative skin phenotypes.
• JNK2 is a negative regulator of cellular proliferation, providing a stress-kinase brake on keratinocyte expansion.
• STAT3 can partly inhibit cell proliferation by directly repressing FST gene expression, illustrating transcriptional control of growth restraint.
• Inflammatory and metabolic inputs, including diet-derived signals and IL-17A, modulate keratinocyte proliferation and comedogenesis in acne and psoriasis.
• miR-155 promotes inflammatory responses in HaCaT keratinocytes via the IRF2BP2/KLF2/NF-kB pathway, linking microRNA networks to keratinocyte growth control.
Description
Keratinocytes are the predominant cell type of the epidermis, and their proliferation must be tightly balanced against differentiation to maintain a functional skin barrier. GO:0010839, negative regulation of keratinocyte proliferation, captures the biological processes that decrease the rate, frequency or extent of keratinocyte multiplication, preventing uncontrolled epidermal expansion. This GO term is essential for researchers because loss of proliferative restraint underlies hyperproliferative skin diseases such as psoriasis and acne, while excessive restraint can impair wound healing. Understanding the molecular brakes on keratinocyte proliferation therefore has direct implications for inflammatory dermatoses, barrier repair and regenerative medicine. Mechanistically, negative regulation of keratinocyte proliferation is not a single pathway but an integrated network of receptor signaling, stress kinases, transcription factors and microRNAs. For example, TLR4 functions as a negative regulator of keratinocyte proliferation, and its modulation changes epidermal growth behavior. The stress kinase JNK2 also acts as a negative regulator of cellular proliferation, providing a brake that can be engaged by environmental or inflammatory stress. At the transcriptional level, STAT3 can partly inhibit cell proliferation by directly repressing FST gene expression, showing how cytokine-activated transcription factors can restrain growth. In disease contexts, the balance between proliferation and restraint is frequently disturbed. Diet-derived metabolic signals, inflammation and comedogenesis are linked in acne pathogenesis, where altered keratinocyte proliferation contributes to follicular plugging. In psoriasis, IL-17A-mediated proliferation and inflammatory responses are negatively regulated by PRELP, and miR-155 promotes inflammatory responses in HaCaT cells via the IRF2BP2/KLF2/NF-kB pathway. In atopic dermatitis, progression from acute to chronic disease is associated with quantitative rather than qualitative changes in cytokine responses, highlighting how inflammatory tone shapes keratinocyte behavior. These examples show why GO:0010839 is a central node for skin biology and therapeutic target discovery.
negative regulation of keratinocyte proliferation At A Glance
| GO ID | GO:0010839 |
|---|---|
| GO term | negative regulation of keratinocyte proliferation |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any process that decreases the rate, frequency or extent of keratinocyte proliferation; keratinocyte proliferation is the multiplication or reproduction of keratinocytes, resulting in the expansion of a cell population. |
| Major function | Restrains epidermal keratinocyte expansion and prevents hyperproliferative skin phenotypes. |
| Representative regulators | TLR4, JNK2, STAT3, miR-155, PRELP. |
| Associated diseases | Acne, psoriasis, atopic dermatitis, impaired wound healing. |
| Research relevance | Target discovery for inflammatory skin disease, barrier repair and regenerative medicine. |
What Is GO:0010839?
GO:0010839, negative regulation of keratinocyte proliferation, is a biological process that decreases the rate, frequency or extent of keratinocyte proliferation. Keratinocyte proliferation itself is the multiplication or reproduction of keratinocytes, resulting in expansion of a cell population. In practical terms, this GO term covers any signaling, transcriptional, post-transcriptional or metabolic mechanism that puts a brake on keratinocyte division, thereby limiting epidermal hyperplasia and helping to preserve tissue homeostasis.
Why Is negative regulation of keratinocyte proliferation Important in Cell Biology?
Negative regulation of keratinocyte proliferation is important because the epidermis must constantly renew while avoiding uncontrolled hyperplasia. When this brake fails, keratinocytes can expand excessively, contributing to inflammatory skin diseases such as psoriasis and acne, whereas excessive restraint can delay re-epithelialization during wound healing. Studying GO:0010839 therefore informs both disease mechanism and therapeutic strategy, including anti-inflammatory and pro-repair interventions.
• Maintains epidermal homeostasis by limiting keratinocyte population expansion.
• Prevents hyperproliferative phenotypes associated with inflammatory skin disease.
• Modulates acne pathogenesis through diet, metabolomics, inflammation and comedogenesis.
• Supports wound healing by balancing keratinocyte activation with growth restraint.
• Provides a mechanistic link between cytokine signaling and keratinocyte growth control.
• Involves stress kinases such as JNK2 that act as negative regulators of cellular proliferation.
• Is influenced by microRNA networks, including miR-155 in HaCaT keratinocytes.
• Offers candidate targets such as TLR4, STAT3, PRELP and KLF2 for experimental dermatology.
• Helps explain quantitative cytokine changes during acute-to-chronic atopic dermatitis progression.
• Guides CRISPR-based functional studies of proliferation brakes in keratinocyte models.
What Happens During negative regulation of keratinocyte proliferation?
Receptor-level braking by TLR4 and innate immune signals
In simple terms: Certain surface receptors act like brakes on keratinocyte division.
TLR4 has been identified as a negative regulator of keratinocyte proliferation, meaning that TLR4 signaling restrains keratinocyte multiplication rather than promoting it. This places innate immune recognition at the center of epidermal growth control and suggests that manipulating TLR4 activity can shift keratinocytes between proliferative and restrained states. Because TLR4 responds to microbial and damage-associated cues, this braking mechanism links the skin microbiome and injury signals to epidermal homeostasis.
Stress kinase control through JNK2
In simple terms: Stress-activated kinases can put a brake on cell division.
JNK2 is a negative regulator of cellular proliferation, providing a stress-responsive brake on cell cycle progression. In keratinocytes, this type of stress kinase signaling can counteract proliferative stimuli generated by inflammation or environmental stress, helping to prevent excessive epidermal expansion. The JNK2 axis therefore represents a node where stress inputs are converted into growth restraint, and it is a plausible target for modulating keratinocyte proliferation in disease models.
Transcriptional repression by STAT3 and FST
In simple terms: Some transcription factors slow growth by turning down specific genes.
STAT3 can partly inhibit cell proliferation via direct negative regulation of FST gene expression. This demonstrates that cytokine-activated transcription factors are not uniformly pro-proliferative; instead, they can impose transcriptional brakes on growth programs. In keratinocyte biology, such transcriptional control provides a mechanism by which inflammatory signaling can paradoxically restrain proliferation, contributing to the complex balance observed in chronic skin inflammation.
MicroRNA and inflammatory network modulation
In simple terms: Small RNA molecules can tune inflammatory and growth signals in skin cells.
miR-155 promotes an inflammatory response in HaCaT cells via the IRF2BP2/KLF2/NF-kB pathway in psoriasis, illustrating how microRNAs reshape keratinocyte signaling networks. PRELP negatively regulates IL-17A-mediated proliferation and the inflammatory response in psoriasis, providing a direct example of a matricellular protein that restrains keratinocyte proliferation under inflammatory conditions. Together, these pathways show that negative regulation of keratinocyte proliferation is embedded within broader inflammatory circuits that can be targeted experimentally.
Metabolic and dietary inputs in acne comedogenesis
In simple terms: Diet and metabolism can influence how fast skin cells grow.
Diet is linked to acne metabolomics, inflammation and comedogenesis, processes in which altered keratinocyte proliferation contributes to follicular plugging. This connection indicates that metabolic signals can modulate the negative regulation of keratinocyte proliferation, either directly or through inflammatory intermediates. Studying these inputs helps explain why nutritional and metabolic status can influence hyperproliferative skin conditions.
Integration with wound healing and autophagy
In simple terms: Growth restraint is coordinated with repair processes after injury.
Keratinocyte autophagy enables the activation of keratinocytes and fibroblasts and facilitates wound healing, showing that degradative and growth-control pathways are coupled during repair. Negative regulation of keratinocyte proliferation must therefore be temporally coordinated with activation programs so that re-epithelialization occurs without excessive hyperplasia. This integration highlights the importance of context-dependent braking in regenerative responses.
Key Genes Involved in GO:0010839 negative regulation of keratinocyte proliferation
The following genes and proteins have been experimentally implicated in negative regulation of keratinocyte proliferation or in closely related growth-control pathways in keratinocytes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TLR4 | Negative regulator of keratinocyte proliferation | Target for modulating epidermal growth and innate immune signaling |
| JNK2 | Negative regulator of cellular proliferation | Stress-kinase brake on keratinocyte expansion |
| STAT3 | Partly inhibits proliferation via repression of FST | Transcription factor linking cytokine signaling to growth restraint |
| FST | Target of STAT3-mediated repression | Effector of transcriptional growth inhibition |
| PRELP | Negatively regulates IL-17A-mediated proliferation in psoriasis | Matricellular brake on inflammatory keratinocyte growth |
| IL-17A | Drives proliferation and inflammation in psoriasis | Inflammatory stimulus counteracted by PRELP |
| KLF2 | Component of IRF2BP2/KLF2/NF-kB pathway in HaCaT cells | Transcription factor node in miR-155 inflammatory signaling |
| IRF2BP2 | Component of miR-155-regulated pathway | Mediator of inflammatory responses in keratinocytes |
| NF-kB | Inflammatory transcription factor downstream of miR-155 | Central regulator of keratinocyte inflammatory responses |
| miR-155 | Promotes inflammatory response in HaCaT cells | MicroRNA modulator of keratinocyte signaling |
| Autophagy machinery | Enables keratinocyte and fibroblast activation for wound healing | Couples degradation pathways to growth control |
| Diet/metabolic factors | Linked to acne metabolomics and comedogenesis | Environmental inputs shaping keratinocyte proliferation |
| Cytokine networks | Quantitative changes during atopic dermatitis progression | Inflammatory context for keratinocyte growth control |
How Is negative regulation of keratinocyte proliferation Regulated?
Negative regulation of keratinocyte proliferation is controlled by multiple layers of regulation. Receptor-level control by TLR4 restrains keratinocyte multiplication and integrates innate immune cues. Stress kinase signaling through JNK2 provides a brake on cellular proliferation that can be engaged by environmental or inflammatory stress. Transcriptionally, STAT3 can partly inhibit proliferation by directly repressing FST gene expression, showing that cytokine-activated factors can impose growth restraint. MicroRNA networks, including miR-155 acting through IRF2BP2/KLF2/NF-kB, modulate inflammatory and proliferative responses in keratinocytes. In psoriasis, PRELP negatively regulates IL-17A-mediated proliferation and inflammation, providing an extracellular brake on cytokine-driven growth. Metabolic and dietary inputs also influence these processes, as illustrated by links between diet, acne metabolomics and comedogenesis. Finally, autophagy supports keratinocyte activation during wound healing, indicating that growth restraint is coordinated with degradative and repair pathways.
negative regulation of keratinocyte proliferation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TLR4 | Hyperproliferative skin phenotypes and innate immune dysregulation | TLR4 knockout keratinocytes and skin equivalents |
| PRELP | Psoriasis and IL-17A-mediated proliferation | PRELP overexpression in keratinocyte cultures and psoriasis models |
| miR-155 | Psoriasis-associated inflammation in HaCaT cells | miR-155 mimic/inhibitor in HaCaT keratinocytes |
| STAT3 | Cytokine-driven growth control via FST repression | STAT3 knockout or point-mutant keratinocyte lines |
| JNK2 | Stress-related proliferation control | JNK2 knockout keratinocytes and stress challenge models |
Psoriasis and inflammatory hyperproliferation
Psoriasis is characterized by excessive keratinocyte proliferation and inflammation. PRELP negatively regulates IL-17A-mediated proliferation and the inflammatory response in psoriasis, indicating that loss of such brakes contributes to disease. miR-155 promotes an inflammatory response in HaCaT cells via the IRF2BP2/KLF2/NF-kB pathway, further linking microRNA-driven inflammation to keratinocyte behavior in psoriasis. These findings position negative regulation of keratinocyte proliferation as a therapeutic axis in psoriatic skin.
Acne and comedogenesis
Acne pathogenesis involves diet-linked metabolomic changes, inflammation and comedogenesis, processes in which keratinocyte proliferation and follicular plugging are central. When negative regulation of keratinocyte proliferation is insufficient, hyperproliferative changes can contribute to comedone formation. This makes GO:0010839 relevant to understanding how metabolic and inflammatory inputs converge on the pilosebaceous unit.
Atopic dermatitis progression
Progression from acute to chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responses, indicating that the magnitude of inflammatory signaling shapes keratinocyte behavior over time. Such quantitative shifts can alter the balance between proliferation and its negative regulation, contributing to chronic barrier dysfunction. Studying GO:0010839 in this context helps explain how inflammatory tone modulates epidermal growth.
Wound healing and regenerative failure
Keratinocyte autophagy enables the activation of keratinocytes and fibroblasts and facilitates wound healing, showing that growth-control pathways are essential for repair. If negative regulation of keratinocyte proliferation is dysregulated, re-epithelialization may be impaired or excessive, leading to poor healing outcomes. This connection highlights the importance of context-dependent braking in regenerative medicine.
From negative regulation of keratinocyte proliferation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of TLR4 increase keratinocyte proliferation? | TLR4 knockout keratinocyte cell line |
| Does PRELP restrain IL-17A-driven proliferation? | PRELP overexpression in keratinocytes and psoriasis-like models |
| How does STAT3 repress FST to inhibit proliferation? | STAT3 knockout or point-mutation keratinocyte models |
| What is the role of JNK2 as a proliferation brake? | JNK2 knockout keratinocytes under stress |
| How does miR-155 modulate inflammatory signaling in keratinocytes? | miR-155 mimic/inhibitor in HaCaT cells |
| How do metabolic inputs affect comedogenesis? | Diet/metabolite-treated keratinocyte and sebocyte co-cultures |
How to Study the negative regulation of keratinocyte proliferation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| EdU/BrdU incorporation | DNA synthesis and proliferation rate | Testing TLR4 or JNK2 knockout keratinocytes |
| Ki-67 staining | Fraction of cycling cells | Quantifying epidermal proliferation in models |
| RNA sequencing | Global transcriptional changes | Identifying STAT3- or KLF2-dependent programs |
| Phospho-proteomics | Kinase pathway activation | Assessing JNK2 and NF-kB signaling |
| Cytokine arrays | Inflammatory mediator secretion | Psoriasis and atopic dermatitis models |
| microRNA profiling | Expression of regulatory microRNAs | miR-155 studies in HaCaT cells |
| Live-cell imaging | Real-time division dynamics | Monitoring proliferation restraint over time |
| Autophagy flux assays | Degradative pathway activity | Wound healing and keratinocyte activation studies |
Proliferation assays and live-cell imaging
Measuring keratinocyte proliferation is the primary way to assess negative regulation. EdU or BrdU incorporation, Ki-67 staining and live-cell imaging can quantify division rates in control versus genetically modified keratinocytes. These assays are typically applied to TLR4 or JNK2 knockout cells to test whether removing a brake increases proliferation.
Transcriptomic and pathway analysis
RNA sequencing and pathway enrichment can identify transcriptional programs downstream of regulators such as STAT3, KLF2 and NF-kB. Comparing control and knockout keratinocytes reveals gene sets related to proliferation, inflammation and differentiation. This approach is useful for placing candidate genes within the GO:0010839 network.
Protein and phosphorylation profiling
Western blotting and phospho-proteomics can measure activation of stress kinases such as JNK2 and transcription factors such as STAT3 and NF-kB. These methods determine whether a candidate regulator signals through known growth-control pathways. They are often combined with proliferation readouts to establish causality.
Inflammatory cytokine and microRNA profiling
Cytokine arrays and microRNA quantification can capture inflammatory tone in keratinocyte cultures, as shown for miR-155 and IL-17A-related pathways. Such profiling helps link negative regulation of keratinocyte proliferation to disease-relevant inflammatory networks. It is particularly useful in psoriasis and atopic dermatitis models.
How CRISPR Can Be Used to Study GO:0010839 negative regulation of keratinocyte proliferation
Knockout
CRISPR knockout of candidate brakes such as TLR4 or JNK2 allows researchers to test whether removing a negative regulator increases keratinocyte proliferation. Knockout keratinocyte lines can be compared with wild-type controls using EdU incorporation and Ki-67 staining. This approach directly interrogates the causal role of a gene in GO:0010839.
Point Mutation
Point mutations can be introduced into signaling domains of receptors or kinases to dissect which residues are required for growth restraint. For example, mutating phosphorylation sites in JNK2 or TLR4 signaling adaptors can reveal how specific modifications control proliferation. Such models are valuable when complete knockout causes confounding developmental effects.
Knock-in
Knock-in of tagged or reporter alleles enables tracking of endogenous proteins such as STAT3 or KLF2 in keratinocytes. Tagged knock-in lines can be used for chromatin immunoprecipitation or imaging to define where and when the regulator acts. This provides spatial and temporal resolution of negative regulation of keratinocyte proliferation.
Overexpression
Overexpression of candidate brakes such as PRELP can test whether increasing their levels suppresses IL-17A-driven proliferation and inflammation. Overexpression models are also useful for microRNA studies, such as miR-155 mimics in HaCaT cells. These experiments help establish sufficiency of a regulator for restraining keratinocyte growth.
How EDITGENE Supports negative regulation of keratinocyte proliferation Research
Researchers studying negative regulation of keratinocyte proliferation-related genes often need to determine whether a candidate gene is causally involved in restraining keratinocyte growth, and which signaling nodes are required for that effect. EDITGENE provides CRISPR-based cell model services that enable loss-of-function, precise mutation, tagging and overexpression studies in keratinocyte and related cell systems, supporting mechanistic and translational research on GO:0010839.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of keratinocyte proliferation research.
Frequently Asked Questions About negative regulation of keratinocyte proliferation
What is GO:0010839?
GO:0010839 is the Gene Ontology term for negative regulation of keratinocyte proliferation, defined as any process that decreases the rate, frequency or extent of keratinocyte proliferation.
What does negative regulation of keratinocyte proliferation mean?
It means biological mechanisms that put a brake on keratinocyte division, limiting epidermal cell population expansion and helping to prevent hyperproliferative skin phenotypes.
What genes are involved in negative regulation of keratinocyte proliferation?
Genes and proteins implicated include TLR4, JNK2, STAT3, FST, PRELP, KLF2, IRF2BP2, NF-kB and miR-155.
How does TLR4 regulate keratinocyte proliferation?
TLR4 acts as a negative regulator of keratinocyte proliferation, meaning its signaling restrains keratinocyte multiplication.
What is the role of JNK2 in keratinocyte growth control?
JNK2 is a negative regulator of cellular proliferation and provides a stress-responsive brake on cell division.
How is STAT3 linked to negative regulation of keratinocyte proliferation?
STAT3 can partly inhibit cell proliferation via direct negative regulation of FST gene expression.
What diseases involve defective negative regulation of keratinocyte proliferation?
Psoriasis, acne, atopic dermatitis and impaired wound healing have been linked to altered keratinocyte growth control.
How does PRELP affect keratinocyte proliferation in psoriasis?
PRELP negatively regulates IL-17A-mediated proliferation and the inflammatory response in psoriasis.
What is the role of miR-155 in keratinocytes?
miR-155 promotes an inflammatory response in HaCaT cells via the IRF2BP2/KLF2/NF-kB pathway in psoriasis.
How can CRISPR be used to study negative regulation of keratinocyte proliferation?
CRISPR knockout, point mutation, knock-in and overexpression models can test whether candidate genes causally restrain keratinocyte proliferation.
Conclusion
GO:0010839, negative regulation of keratinocyte proliferation, defines the biological brakes that limit epidermal keratinocyte expansion. Experimental evidence implicates receptor signaling through TLR4, stress kinase control by JNK2, transcriptional repression by STAT3, microRNA networks involving miR-155, and matricellular regulation by PRELP in this process. These pathways are directly relevant to psoriasis, acne, atopic dermatitis and wound healing, making GO:0010839 a valuable framework for skin disease research. CRISPR-based cell models provide a rigorous way to test causality and dissect mechanism within this GO term. By combining knockout, point mutation, knock-in and overexpression strategies with proliferation, transcriptomic and inflammatory readouts, researchers can identify new negative regulators of keratinocyte proliferation and translate them into therapeutic hypotheses.
References
- 1. Melnik BC. 2015. Linking diet to acne metabolomics, inflammation, and comedogenesis: an update.. Clin Cosmet Investig Dermatol 8:371-88 PMID: 26203267
- 2. Qiang L et al.. 2021. Keratinocyte autophagy enables the activation of keratinocytes and fibroblastsand facilitates wound healing.. Autophagy 17(9):2128-2143 PMID: 32866426
- 3. Iotzova-Weiss G et al.. 2017. TLR4 as a negative regulator of keratinocyte proliferation.. PLoS One 12(10):e0185668 PMID: 28982115
- 4. Chen L et al.. 2024. miR‑155 promotes an inflammatory response in HaCaT cells via the IRF2BP2/KLF2/NF‑κB pathway in psoriasis.. Int J Mol Med 54(5) PMID: 39219281
- 5. Tsoi LC et al.. 2020. Progression of acute-to-chronic atopic dermatitis is associated with quantitative rather than qualitative changes in cytokine responses.. J Allergy Clin Immunol 145(5):1406-1415 PMID: 31891686
- 6. Xu H et al.. 2021. STAT3 Partly Inhibits Cell Proliferation via Direct Negative Regulation of FST Gene Expression.. Front Genet 12:678667 PMID: 34239543
- 7. Sabapathy K et al.. 2004. JNK2: a negative regulator of cellular proliferation.. Cell Cycle 3(12):1520-3 PMID: 15611655
- 8. He CC et al.. 2026. PRELP negatively regulates IL-17A-mediated proliferation and the inflammatory response in psoriasis.. Signal Transduct Target Ther 11(1) PMID: 42204138
